Font Size:
a
A
A
Keyword [CI-1033]
Result: 1 - 1 | Page: 1 of 1
1.
The combination of pan-ErbB tyrosine kinase inhibitor CI-1033 and lovastatin: A potential novel therapeutic approach in squamous cell carcinoma of the head and neck
<<First
<Prev Next>
Last>>
Jump to